Mary L. Johnson, RN, BS, CDCES
Director, Administration and Clinical Research, International Diabetes Center
About
Affiliation
positions
  • Director, Administration and Clinical Research, International Diabetes Center
    • Publications While At HealthPartners
    selected publications
    Journal Article
  • -cell function over time on glycemic outcomes in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE): differential treatment effects of dual therapy. 
    Diabetes care. 2024
  • Continuous glucose monitoring prediction of gestational diabetes mellitus and perinatal complications. 
    Diabetes Technology & Therapeutics. 2024
  • Continuous glucose monitoring profiles in pregnancies with and without gestational diabetes mellitus. 
    Diabetes care. 2024
  • Continuous glucose monitoring-derived differences in pregnancies with and without adverse perinatal outcomes. 
    Obstetrics and Gynecology. 2024
  • Expert panel recommendations for a standardized ambulatory glucose profile report for connected insulin pens. 
    Diabetes Technology & Therapeutics. 2024
  • Glucose levels measured with continuous glucose monitoring in uncomplicated pregnancies. 
    BMJ open diabetes research & care. 2024
  • The use of rescue insulin in the glycemia reduction approaches in diabetes: a comparative effectiveness study (GRADE). 
    Diabetes care. 2024
  • Comprehensive telehealth model to support diabetes self-management. 
    JAMA network open. 2023
  • A comparison of postprandial glucose control in the Medtronic advanced hybrid closed-loop system versus 670G. 
    Diabetes Technology & Therapeutics. 2022
  • A safe and simple algorithm for adding and adjusting mealtime insulin to basal-only therapy. 
    Clinical Diabetes. 2022
  • Comparing patch vs pen bolus insulin delivery in type 2 diabetes using continuous glucose monitoring metrics and profiles. 
    Journal of Diabetes Science and Technology. 2022
  • Continuous glucose monitoring in adults with type 1 diabetes with 35 years duration from the DCCT/EDIC Study. 
    Diabetes care. 2022
  • Islet autoimmunity is highly prevalent and associated with diminished β-cell function in patients with type 2 diabetes in the Grade Study. 
    Diabetes. 2022
  • Randomized comparison of self-monitored blood glucose (BGM) versus continuous glucose monitoring (CGM) data to optimize glucose control in type 2 diabetes. 
    Journal of Diabetes and Its Complications. 2022
  • A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial. 
    Lancet (London, England). 2021
  • Comparison of central laboratory HbA1c measurements obtained from a capillary collection versus a standard venous whole blood collection in the GRADE and EDIC studies. 
    PloS One. 2021
  • Effect of professional CGM (pCGM) on glucose management in type 2 diabetes patients in primary care. 
    Journal of Diabetes Science and Technology. 2021
  • Diabetes telehealth solutions: improving self-management through remote initiation of continuous glucose monitoring. 
    Journal of the Endocrine Society. 2020
  • International Diabetes Center: COVID-19 won't stop us from fulfilling our mission. 
    Journal of Diabetes Science and Technology. 2020
  • Automated insulin dosing guidance to optimise insulin management in patients with type 2 diabetes: a multicentre, randomised controlled trial. 
    Lancet (London, England). 2019
  • Implementation of basal-bolus therapy in type 2 diabetes: a randomized controlled trial comparing bolus insulin delivery using an insulin patch with an insulin pen. 
    Diabetes Technology & Therapeutics. 2019
  • Insulin dosing guidance to optimise type 2 diabetes management - authors' reply. 
    Lancet (London, England). 2019
  • Rationale and design for a GRADE substudy of continuous glucose monitoring. 
    Diabetes Technology & Therapeutics. 2019
  • The relationships between time in range, hyperglycemia metrics, and HbA1c. 
    Journal of Diabetes Science and Technology. 2019
  • Can a tool that automates insulin titration be a key to diabetes management?. 
    Diabetes Technology & Therapeutics. 2012
  • Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort. 
    Archives of Internal Medicine. 2011
  • Adjust to target in type 2 diabetes: comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine. 
    Diabetes care. 2008
  • Creatinine clearance and blood pressure: a 34-year circadian study. 
    Clinica Terapeutica. 2008
  • Impact of modem-transferred blood glucose data on clinician work efficiency and patient glycemic control. 
    Diabetes Technology & Therapeutics. 2005
  • Clinical impact of prandial state, exercise, and site preparation on the equivalence of alternative-site blood glucose testing. 
    Diabetes care. 2003
    • Conference Poster
  • Effect of professional CGM (pCGM) on glucose management in type 2 diabetes patients in primary care [poster]
    2019
  • Comparing patch vs.pen bolus insulin delivery in type 2 diabetes using continuous glucose monitoring metrics and profiles [poster]
    2018
  • Optimizing basal-bolus therapy in T2D—a randomized controlled trial comparing bolus insulin delivery using an insulin patch vs. an insulin pen [poster]
    2018
    • Review
  • Utilizing the ambulatory glucose profile to standardize and implement continuous glucose monitoring in clinical practice [review]. 
    Diabetes Technology & Therapeutics. 2019
    • presentations
    Contact
    full name
  • Mary L. Johnson, RN, BS, CDCES
    • Quick Info
     
    Collaboration